The company said the results support the drug’s potential to transform the treatment of hypophosphatasia and it plans to ...
A phase 3 trial of AstraZeneca’s rare metabolic disease prospect has missed its primary endpoint, raising doubts about the ...
A key question for ESO-T01 and other in vivo candidates will be the durability of their cancer eradication. While the ...
March 27 (Reuters) - AstraZeneca said on Friday its experimental respiratory treatment tozorakimab showed a meaningful ...
The trial has an overall status of “Completed,” which means dosing and follow-up are finished. The study was first submitted to the registry on July 17, 2025, and the most recent update was filed on ...
AstraZeneca’s drug candidate baxdrostat lowered systolic blood pressure in a phase 3 clinical trial involving patients with uncontrolled or treatment-resistant hypertension. In the trial, patients who ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A U.S. flag stands next to the AstraZeneca logo during a signing event for documents related to a manufacturing site ...
AstraZeneca has a tiered partnership model to meet sites where they are. Sites can move between the levels as their capacity and engagement evolves over time, but all levels provide the site with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results